RenovoRx (RNXT) Stock: Buy, Sell, or Hold?
RNXT - RenovoRx, Inc. Common Stock
$1.58
0.03 (1.94%)
▲
5d:
-4.82%
30d:
-37.3%
90d:
+66.74%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 12, 2026
Get Alerted When RNXT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RNXT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RNXT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RNXT is currently trading at $1.58, which is considered slightly low relative to its 30-day fair value range of $1.43 to $2.07.
Technical Outlook: Technically, RNXT is in a strong uptrend. Immediate support is located at $1.50, while resistance sits at $1.80.
Market Sentiment: RNXT scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.12 (+350.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RNXT is in a strong uptrend. Immediate support is located at $1.50, while resistance sits at $1.80.
Market Sentiment: RNXT scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.12 (+350.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.43 -
$2.07
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 350.9% below Wall St target ($7.12)
- CAUTION: Bottoming setup, but lagging the sector by 47% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$1.43 -
$2.07
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.50
Resistance Level
$1.80
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.17
Wall Street Target
$7.13
(+350.9%)
Revenue Growth (YoY)
115.4%
Share & Embed Analysis
Last updated: October 04, 2026 3:31 AM ET
Data refreshes hourly during market hours. Next update: 4:31 AM
Data refreshes hourly during market hours. Next update: 4:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RNXT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 49 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 52 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$47 | 46 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$851 | 48 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$293 | 67 BUY |
